01 Coagulation
Last updated
Last updated
occurs before any thrombus formation
coagulation = fibrin formation into clot to stop blood loss
First soluble. Become insoluble when activated
fibrin insoluble, precipitate
when endothelium intact, no contact
when damaged, tissue factors expressed
not very effective, no amplification
thrombin amplification
5, 8, 11 activate more 10
hemophilia: low 8 or 9
unique: in endothelium
megakaryocytes: von willebrand stored in platelets and endothelium
injury: factor 8 released from vWF, thrombin formation
formed but not crosslinked
activate coagulation system when exposed to silica
how written in textbook
1st pathway: TF pathway from TF:VIIa
2nd pathway: factor 12
T: which factors activated by thrombin
phospholipid: required, exists on TF cells or platelets
needed in both pathways
used to be called factor 4
contact pathway: activated when plasma in contact with negatively charged substances
link between coagulation and inflammation
generated by factor 12
factor 12 leads to synthesis of bradykinin
link between coagulation system and kinin system (inflammation)
cannot activate bradykinin
routine test of PTT shows prolonged. No medical problems because 12 doesn't have a lot of physiologic significance
activated by healthy endothelial cells
healthy endothelium: produce lots of thrombomodulin, less thrombin
deficiency in one or both: hypercoagulable
factor 5 leiden mutation: cannot be inactivated by protein C/S: hypercoagulable
just know plasma level increased with heparin
Tissue factor pathway inhibitor (or TFPI) is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-tissue factor complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5 nM.
break down fibrin
converted to active in plasma
break up thrombus
contain crosslinked bond by 13
indicates crosslinked fibrin clot broken down
FDP can increase without clot formation: not useful
break down of fibrinogen but not clot
break down other clotting factors: deplete clotting factors
looks like DIC
increased in prostate cancer and cirrhosis
alpha2- antiplasmin inhibitor of plasmin. Loss can leads to overactivation
inflammation: increased protein levels
proteins are sticky, clump RBCs together, settle faster to bottom faster
liver makes more fibrinogen that will increase ESR